These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6140786)

  • 1. [Ranitidine (Zantac). A new H2 receptor antagonist].
    Bendtsen F; Danø P
    Ugeskr Laeger; 1983 Nov; 145(47):3681-2. PubMed ID: 6140786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Visible spectrophotometric assay of ranitidine].
    Apostu M; Dorneanu V; Bibire N
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):214-7. PubMed ID: 14756000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
    Senfft U
    Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ranitidine: a new histamine H2 receptor blockader].
    Duan ZB
    Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):309-12. PubMed ID: 2874962
    [No Abstract]   [Full Text] [Related]  

  • 11. Ranitidine v. cimetidine in peptic ulcer.
    Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
    [No Abstract]   [Full Text] [Related]  

  • 12. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine].
    Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P
    Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK; Sung JJ
    N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the histamine H2-receptor antagonist zantac on lipid peroxidation an antioxidant system in patients with gastroduodenal hemorrhage of ulcer etiology].
    Ermolov AS; Pakhomova GV; Taeritneva LF; Matveev SB; Marchenko VV; Golikov PP
    Patol Fiziol Eksp Ter; 1996; (1):23-5. PubMed ID: 8657447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
    Preiser JC
    BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.